首頁 > 市場調查報告書 > 醫療設備

體外診斷泌尿科

市場調查報告書

商品編碼

1623514

按類型、應用程式、最終用戶、地區、範圍和預測劃分的全球尿液檢測市場規模

Global Urinalysis Market Size By Type (Instruments, Consumables), By Application (Disease Screening, Pregnancy and Fertility Testing), By End-User (Clinical Laboratories, Hospitals, Home Care), By Geographic Scope and Forecast

出版日期: 2024年09月12日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

尿液檢測市場規模及預測

2023年尿液檢測市場規模為20.7億美元，預計到2031年將達到39.1億美元，2024年至2031年複合年增長率為8.30%。尿液分析是指透過檢測尿液樣整體評估健康狀況、檢測疾病和監測各種醫療狀況的診斷過程。此檢測廣泛用於臨床實驗室和醫療機構，用於診斷泌尿道感染、腎臟疾病、糖尿病和肝損傷等疾病。

尿液檢測的未來充滿希望，技術的進步帶來了檢測方法的創新，包括即時檢測設備和自動尿液檢測系統的開發。

全球尿液檢測市場動態

塑造全球尿液檢測市場的主要市場動態是：

主要市場推動因素

泌尿道感染 (UTI) 的發生率增加：

全球每年約發生 1.5 億例泌尿道感染，因此對尿液檢測產生了巨大的需求，以有效診斷和管理這些疾病。

糖尿病盛行率增加：

截至 2021 年，全球估計有 5.37 億成年人患有糖尿病，這增加了定期尿液檢測以監測血糖水平和預防併發症的需求，進一步推動了市場成長。

技術進步：

到 2025 年，全球即時檢測設備市場預計將達到 606 億美元，推動尿液檢測技術的創新並擴大其在各種醫療保健環境中的應用。

強調預防保健：

到 2022 年，全球醫療保健支出預計將達到 10 兆美元，各國政府和衛生組織越來越多地推廣預防性醫療保健。

主要課題

準確性和可靠性問題：

由於人為錯誤或樣本處理不當導致的結果變化可能會影響尿液檢測的準確性，並對臨床決策帶來課題。

遵守法規：

嚴格的診斷測試監管標準和指南可能會使新尿液檢測設備和技術的審批過程變得複雜。

先進技術成本高：

自動化先進尿液檢測系統的實施可能會因其高昂的成本而受到阻礙，這限制了小型醫療機構的使用。

新興市場認知度低：

特別是在新興市場，人們往往缺乏對尿液檢測在醫療保健中重要性的認識和教育，這可能會限制市場的成長。

主要趨勢：

人工智慧（AI）整合：

將人工智慧和機器學習演算法納入尿液檢測過程可增強結果解釋、提高診斷準確性並簡化工作流程。

家庭測試的興起：

消費者對家庭健康監測解決方案的需求不斷增長，推動了易於使用的尿液檢測套件的開發，這些套件可以在舒適的家中進行。

個人化醫療的方法：

個人化醫療的趨勢日益增長，尿液檢測可以整合到量身定制的醫療計劃中，從而實現更好的疾病管理和監測。

擴展遠距醫療服務：

遠距醫療平台的興起正在促進遠距諮詢和監測，改善尿液分析服務的可近性，並能夠及時介入和管理健康狀況。

概述
北美
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 亞太其他地區
拉丁美洲
- 巴西
- 阿根廷
- 其他拉丁美洲
中東/非洲
- 阿拉伯聯合酋長國
- 沙烏地阿拉伯
- 南非
- 其他中東和非洲

第9章全球尿液檢測市場競爭格局

概述
企業市場排名
重大發展
公司區域足跡
按行業劃分的企業足跡
ACE矩陣

第10章公司簡介

Cardinal Health
Roche Diagnostics
Sysmex Corporation
Beckman Coulter
Arkray Inc.Abbott
Siemens Healthcare GmbH
ACON Laboratories
Shenzhen Mindray Bio-Medical Electronics
F. Hoffmann-La Roche
Quidel Corporation
Bio-Rad Laboratories
Urit Medical Electronics
77 Elektronika Kft.
Mindray Medical International Limited

第 11 章經驗證的市場情報

關於經過驗證的市場情報
動態資料視覺化

簡介目錄

Product Code: 23989

Urinalysis Market Size and Forecast

Urinalysis Market size was valued at USD 2.07 Billion in 2023 and is projected to reach USD 3.91 Billion by 2031 , growing at a CAGR of 8.30% from 2024 to 2031. urinalysis refers to a diagnostic process that examines urine samples to assess health status, detect diseases, and monitor various medical conditions. This analysis is widely utilized in clinical laboratories and healthcare settings for diagnosing conditions such as urinary tract infections, kidney diseases, diabetes, and liver disorders.

The future of urinalysis is promising, with advancements in technology driving innovation in testing methods, including the development of point-of-care testing devices and automated urinalysis systems.

Global Urinalysis Market Dynamics

The key market dynamics that are shaping the global urinalysis market include:

Key Market Drivers

Rising Incidence of Urinary Tract Infections (UTIs):

Approximately 150 million urinary tract infections occur globally each year, creating a significant demand for urinalysis to diagnose and manage these conditions effectively.

Growing Prevalence of Diabetes:

With an estimated 537 million adults worldwide living with diabetes as of 2021, the need for regular urinalysis to monitor glucose levels and prevent complications is increasing, further driving market growth.

Technological Advancements:

The global market for point-of-care testing devices is projected to reach $60.6 billion by 2025, fostering innovation in urinalysis technology and expanding its applications in various healthcare settings.

Emphasis on Preventive Healthcare:

Governments and health organizations are increasingly promoting preventive healthcare measures, with global healthcare expenditure projected to reach $10 trillion by 2022, which supports the growth of routine diagnostic tests, including urinalysis.

Key Challenges

Accuracy and Reliability Concerns:

Variability in results due to human error or improper sample handling can affect the accuracy of urinalysis, posing challenges in clinical decision-making.

Regulatory Compliance:

Stringent regulatory standards and guidelines for diagnostic tests can complicate the approval process for new urinalysis devices and technologies.

High Cost of Advanced Technologies:

The adoption of automated and advanced urinalysis systems can be hindered by their high costs, limiting access for smaller healthcare facilities.

Limited Awareness in Emerging Markets:

There is often a lack of awareness and education regarding the importance of urinalysis in healthcare, particularly in developing regions, which can restrict market growth.

Key Trends:

Integration of Artificial Intelligence (AI):

The incorporation of AI and machine learning algorithms into urinalysis processes is enhancing the interpretation of results, improving diagnostic accuracy, and streamlining workflows.

Rise of Home-Based Testing:

Increasing consumer demand for at-home health monitoring solutions is leading to the development of user-friendly urinalysis kits that allow individuals to conduct tests in the comfort of their homes.

Personalized Medicine Approaches:

There is a growing trend towards personalized medicine, where urinalysis is being integrated into tailored healthcare plans, enabling better disease management and monitoring.

Expansion of Telehealth Services:

The rise of telehealth platforms is facilitating remote consultations and monitoring, increasing the accessibility of urinalysis services and allowing for timely intervention and management of health conditions.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Urinalysis Market Regional Analysis

Here is a more detailed regional analysis of the global urinalysis market:

North America:

North America is the dominant region in the global urinalysis market, accounting for a significant share due to its well-established healthcare infrastructure, advanced diagnostic technologies, and high awareness of preventive healthcare. The region's strong emphasis on early disease detection and management contributes to the widespread adoption of urinalysis tests in clinical settings. According to the Centers for Disease Control and Prevention (CDC), approximately 70% of all healthcare decisions are based on laboratory test results, highlighting the critical role of urinalysis in patient care.

The presence of major market players, robust research and development activities, and a strong regulatory framework further enhance North America's market position. The U.S. Food and Drug Administration (FDA) has approved numerous innovative urinalysis products, ensuring that healthcare providers have access to advanced testing solutions. The region's focus on personalized medicine and rapid technological advancements, including point-of-care testing, also bolster the growth of the urinalysis market.

Asia Pacific:

The Asia Pacific region is the fastest-growing market for urinalysis, driven by a combination of increasing healthcare expenditures, a rising population, and growing awareness of preventive healthcare measures. Rapid urbanization and economic growth in countries like China and India have led to a surge in demand for diagnostic testing services, including urinalysis. According to the World Health Organization (WHO), healthcare spending in Asia Pacific is projected to reach $2.4 trillion by 2025, reflecting a strong commitment to improving healthcare access and quality.

The rising prevalence of lifestyle-related diseases, such as diabetes, hypertension, and obesity, is further propelling the demand for urinalysis in the region. For instance, the International Diabetes Federation (IDF) estimates that the number of adults with diabetes in the Asia Pacific region will rise to over 200 million by 2030, necessitating regular monitoring through urinalysis. This growing disease burden creates significant opportunities for market players to introduce innovative testing solutions tailored to the region's specific health challenges.

Global Urinalysis Market Segmentation Analysis

The Global Urinalysis Market is segmented on the basis of By Type, By Application, By End User and By Geography.

Urinalysis Market, By Type

Instruments
Consumables

Based on Type, the Global Urinalysis Market is segmented into Instruments and Consumables. The Instruments is the dominate segment due to the widespread adoption of automated urinalysis systems and analyzers in hospitals and diagnostic laboratories. These instruments offer enhanced accuracy and efficiency in urine testing, making them a crucial part of the diagnostic process. However, the consumables segment is the fastest-growing, driven by the rising demand for test strips, reagents, and disposable items used in both traditional and point-of-care testing.

Urinalysis Market, By Application

Disease Screening
Pregnancy and Fertility Kits

Based on Application, the Global Urinalysis Market is segmented into Disease Screening and Pregnancy & Fertility Kits. The disease screening segment is the dominant segment, driven by its widespread use in detecting conditions such as urinary tract infections, kidney disorders, and diabetes. On the other hand, the pregnancy and fertility kits segment is the fastest-growing, owing to the increasing demand for at-home testing kits that offer convenience and privacy.

Urinalysis Market, By End User

Clinical Laboratories
Hospitals
Home Care

Based on End User, the Global Urinalysis Market is segmented into Disease Screening and Pregnancy & Fertility Kits. The clinical laboratories is the dominating segment due to the widespread use of advanced diagnostic equipment and the high volume of tests conducted in these facilities. On the other hand, the home care segment is the fastest-growing, driven by the increasing demand for at-home diagnostic solutions and the rise of point-of-care testing.

Urinalysis Market, By Geography

North America
Europe
Asia Pacific
Rest of the World

Based on the Geography, the Global Urinalysis Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America is the dominant region in the global urinalysis market, accounting for a significant share due to its well-established healthcare infrastructure, advanced diagnostic technologies, and high awareness of preventive healthcare. The Asia Pacific region is the fastest-growing market for urinalysis, driven by a combination of increasing healthcare expenditures, a rising population, and growing awareness of preventive healthcare measures.

Key Players

The "Global Urinalysis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market
Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific, Bayer AG, F. Hoffmann-La Roche Ltd, Beckman Coulter Life Sciences, Alfa Wassermann Inc., EKF Diagnostics, Trinity Biotech plc, Arkray, Mindray Medical International Limited, and more.
Our
market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Global Urinalysis Market: Recent Developments
In August 2023 Siemens Healthineers announced its acquisition of a cutting-edge urinalysis technology firm focused on developing point-of-care testing solutions.
In July 2023 Becton, Dickinson and Company (BD) launched a new line of enhanced urinalysis reagents, designed to improve the sensitivity and specificity of urinalysis tests.
In June 2023 Abbott announced a strategic partnership with a HealthTech startup specializing in digital health solutions for urinalysis. This collaboration aims to develop a mobile application that allows patients to conduct at-home urinalysis tests and receive real-time feedback on their results.

1 INTRODUCTION OF GLOBAL URINALYSIS MARKET

1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Assumptions
1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

2.1 Data Mining
2.2 Data Triangulation
2.3 Bottom-Up Approach
2.4 Top-Down Approach
2.5 Research Flow
2.6 Key Insights from Industry Experts
2.7 Data Sources

3 EXECUTIVE SUMMARY

3.1 Market Overview
3.2 Ecology Mapping
3.3 Absolute Market Opportunity
3.4 Market Attractiveness
3.5 Global Urinalysis Market Geographical Analysis (CAGR %)
3.6 Global Urinalysis Market, By Type (USD Million)
3.7 Global Urinalysis Market, By Application (USD Million)
3.8 Global Urinalysis Market, By End-User (USD Million)
3.9 Future Market Opportunities
3.10 Global Market Split
3.11 Product Life Line

4 GLOBAL URINALYSIS MARKET OUTLOOK

4.1 Global Urinalysis Evolution
4.2 Drivers
- 4.2.1 Driver 1
- 4.2.2 Driver 2
4.3 Restraints
- 4.3.1 Restraint 1
- 4.3.2 Restraint 2
4.4 Opportunities
- 4.4.1 Opportunity 1
- 4.4.2 Opportunity 2
4.5 Porters Five Force Model
4.6 Value Chain Analysis
4.7 Pricing Analysis
4.8 Macroeconomic Analysis

5 GLOBAL URINALYSIS MARKET, BY TYPE

5.1 Overview
5.2 Cartridges & Capsules
5.3 Syringe Filters
5.4 Bottle-Top Vacuum Filters
5.5 Others

6 GLOBAL URINALYSIS MARKET, BY APPLICATION

6.1 Overview
6.2 Instruments
6.3 Consumables

7 GLOBAL URINALYSIS MARKET, BY END-USER

7.1 Overview
7.2 Clinical Laboratories
7.3 Hospitals
7.4 Home Care
7.5 Others

8 GLOBAL URINALYSIS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Argentina
- 8.5.3 Rest of Latin America
8.6 Middle-East and Africa
- 8.6.1 UAE
- 8.6.2 Saudi Arabia
- 8.6.3 South Africa
- 8.6.4 Rest of Middle-East and Africa

9 GLOBAL URINALYSIS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Developments
9.4 Company Regional Footprint
9.5 Company Industry Footprint
9.6 ACE Matrix

10 COMPANY PROFILES

10.1 Cardinal Health
- 10.1.1 Company Overview
- 10.1.2 Company Insights
- 10.1.3 Product Benchmarking
- 10.1.4 Key Development
- 10.1.5 Winning Imperatives
- 10.1.6 Current Focus & Strategies
- 10.1.7 Threat from Competition
- 10.1.8 SWOT Analysis
10.2 Roche Diagnostics
- 10.2.1 Company Overview
- 10.2.2 Company Insights
- 10.2.3 Product Benchmarking
- 10.2.4 Key Development
- 10.2.5 Winning Imperatives
- 10.2.6 Current Focus & Strategies
- 10.2.7 Threat from Competition
- 10.2.8 SWOT Analysis
10.3 Sysmex Corporation
- 10.3.1 Company Overview
- 10.3.2 Company Insights
- 10.3.3 Product Benchmarking
- 10.3.4 Key Development
- 10.3.5 Winning Imperatives
- 10.3.6 Current Focus & Strategies
- 10.3.7 Threat from Competition
- 10.3.8 SWOT Analysis
10.4 Beckman Coulter
- 10.4.1 Company Overview
- 10.4.2 Company Insights
- 10.4.3 Product Benchmarking
- 10.4.4 Key Development
- 10.4.5 Winning Imperatives
- 10.4.6 Current Focus & Strategies
- 10.4.7 Threat from Competition
- 10.4.8 SWOT Analysis
10.5 Arkray Inc.Abbott
- 10.5.1 Company Overview
- 10.5.2 Company Insights
- 10.5.3 Product Benchmarking
- 10.5.4 Key Development
- 10.5.5 Winning Imperatives
- 10.5.6 Current Focus & Strategies
- 10.5.7 Threat from Competition
- 10.5.8 SWOT Analysis
10.6 Siemens Healthcare GmbH
- 10.6.1 Company Overview
- 10.6.2 Company Insights
- 10.6.3 Product Benchmarking
- 10.6.4 Key Development
- 10.6.5 Winning Imperatives
- 10.6.6 Current Focus & Strategies
- 10.6.7 Threat from Competition
- 10.6.8 SWOT Analysis
10.7 ACON Laboratories
- 10.7.1 Company Overview
- 10.7.2 Company Insights
- 10.7.3 Product Benchmarking
- 10.7.4 Key Development
- 10.7.5 Winning Imperatives
- 10.7.6 Current Focus & Strategies
- 10.7.7 Threat from Competition
- 10.7.8 SWOT Analysis
10.8 Shenzhen Mindray Bio-Medical Electronics
- 10.8.1 Company Overview
- 10.8.2 Company Insights
- 10.8.3 Product Benchmarking
- 10.8.4 Key Development
- 10.8.5 Winning Imperatives
- 10.8.6 Current Focus & Strategies
- 10.8.7 Threat from Competition
- 10.8.8 SWOT Analysis
10.9 F. Hoffmann-La Roche
- 10.9.1 Company Overview
- 10.9.2 Company Insights
- 10.9.3 Product Benchmarking
- 10.9.4 Key Development
- 10.9.5 Winning Imperatives
- 10.9.6 Current Focus & Strategies
- 10.9.7 Threat from Competition
- 10.9.8 SWOT Analysis
10.10 Quidel Corporation
- 10.10.1 Company Overview
- 10.10.2 Company Insights
- 10.10.3 Product Benchmarking
- 10.10.4 Key Development
- 10.10.5 Winning Imperatives
- 10.10.6 Current Focus & Strategies
- 10.10.7 Threat from Competition
- 10.10.8 SWOT Analysis
10.11 Bio-Rad Laboratories
- 10.11.1 Company Overview
- 10.11.2 Company Insights
- 10.11.3 Product Benchmarking
- 10.11.4 Key Development
- 10.11.5 Winning Imperatives
- 10.11.6 Current Focus & Strategies
- 10.11.7 Threat from Competition
- 10.11.8 SWOT Analysis
10.12 Urit Medical Electronics
- 10.12.1 Company Overview
- 10.12.2 Company Insights
- 10.12.3 Product Benchmarking
- 10.12.4 Key Development
- 10.12.5 Winning Imperatives
- 10.12.6 Current Focus & Strategies
- 10.12.7 Threat from Competition
- 10.12.8 SWOT Analysis
10.13 77 Elektronika Kft.
- 10.13.1 Company Overview
- 10.13.2 Company Insights
- 10.13.3 Product Benchmarking
- 10.13.4 Key Development
- 10.13.5 Winning Imperatives
- 10.13.6 Current Focus & Strategies
- 10.13.7 Threat from Competition
- 10.13.8 SWOT Analysis
10.14 Mindray Medical International Limited
- 10.14.1 Company Overview
- 10.14.2 Company Insights
- 10.14.3 Product Benchmarking
- 10.14.4 Key Development
- 10.14.5 Winning Imperatives
- 10.14.6 Current Focus & Strategies
- 10.14.7 Threat from Competition
- 10.14.8 SWOT Analysis